Medicare Definitions Of ‘Bona Fide Marketing,’ And ‘Single-Source Drug’ May Be Inconsistent With Law, Appeals Court Says

 
• By Sarah Karlin-Smith
  
close up of a dictionary on the word "definition"
The consistency between Congress and Medicare's definitions of key terms are at issue in AstraZeneca's case against the IRA. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Litigation

More from Pricing Debate